在重创时立即使用的口服特兰胺酸:对大规模伤亡事件的影响
Matthew Warner1, Jonathon Lowe2,3, Ed Benjamin Graham Barnard3,4
1Emergency Department, British Antarctic Survey Medical Unit, Plymouth, UK.
Emergency medicine journal : EMJ
|January 30, 2025
概括
早期使用的特兰胺酸 (TXA) 降低了创伤患者严重出血的死亡率. 本文探讨了口服TXA作为在大规模伤亡事件中可行的替代途径,以克服管理延迟.
科学领域:
- 紧急医疗 紧急医疗
- 创伤外科 手术 创伤外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 早期服用松酸 (TXA) 显著降低了创伤患者经历重大出血的死亡率.
- 目前的注射途径 (静脉注射,肌内注射) 可能会导致延迟,特别是在大规模伤亡事件 (MCI) 中.
- 如果初始响应者不能给IV/IM药物,则延迟会加剧.
研究的目的:
- 讨论口服松酸 (TXA) 作为替代性施用途径的潜力.
- 在大规模伤亡事件中解决及时TXA管理的挑战.
- 探索在大规模紧急情况下改善TXA可访问性的策略.
主要方法:
- 这是一个概念论文,而不是实验研究.
- 它涉及到对TXA管理现有知识的讨论和分析.
- 这篇论文审查了口服TXA在紧急情况下的可行性.
主要成果:
- 口服TXA提供了一个潜在的解决方案,以克服与MCI中的IV/IM访问相关的延迟.
- 这条路线可能允许更广泛的人员更快地管理.
- 需要进一步的研究来验证口服TXA在创伤中的有效性和最佳剂量.
结论:
- 口服特兰胺酸 (TXA) 为创伤患者在大规模伤亡事件中提供了一种有前途的替代性给药途径.
- 这种方法可以减轻延迟并改善患者的治疗结果.
- 调查口服TXA的疗效和协议对于未来的紧急医疗准备至关重要.
相关概念视频
Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K
Vascular Spasm
1.2K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.2K
Coagulation
4.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.3K


